Altered action of angiotensin II in patients with type 2 diabetes mellitus of recent onset.

ObjectiveAngiotensin II (Ang II) increases insulin sensitivity in healthy volunteers. This effect is thought to be mediated, at least in part, by an increase in skeletal muscle blood flow. In the past it had been documented that some biological actions of Ang II are altered in diabetes. We addressed